Today: 8 June 2026
Walmart stock near a record as WMT heads into first earnings under new CEO
16 February 2026
2 mins read

Walmart stock near a record as WMT heads into first earnings under new CEO

New York, Feb 16, 2026, 11:16 EST — The market is closed.

  • Walmart stock finished 0.2% higher at $133.89. U.S. markets were closed Monday for Presidents Day.
  • Walmart’s market cap now sits around $1.07 trillion, driven by the stock’s 2026 rally.
  • Thursday brings the next catalyst: results and guidance. Key U.S. growth and inflation data land later in the week, adding to the mix.

Walmart Inc (WMT.O) wrapped up Friday at $133.89, ticking 0.2% higher after reaching $134.64 earlier in the session. The retail giant now stands at about $1.07 trillion in market cap, adding close to $179 billion this year alone.

With U.S. cash equity markets shut Monday for Presidents Day, eyes are still on Walmart as trading resumes. Shares have climbed roughly 20% in 2026, pushing Walmart to the top spot by market cap in consumer staples. Investors have been shifting toward defensive stocks, wary of the impact from AI-related capital spending and its ripple effects.

Walmart steps up with its quarterly numbers on Thursday, right in the middle of a packed, holiday-shortened stretch. Investors are bracing for an early read on Q4 GDP, fresh consumer sentiment figures, and the PCE price index—the inflation yardstick watched by the Fed. The retail giant’s results arrive just after December retail sales stalled unexpectedly, though a robust January jobs report helped calm fears of a sudden economic downshift.

This will mark the first earnings report with John Furner at the helm—he stepped into the CEO role on Feb. 1 following Walmart’s executive shake-up and Doug McMillon’s handover. David Guggina has been tapped to lead Walmart U.S., while Seth Dallaire’s job as chief growth officer has been expanded, just a couple of the moves in a broader management overhaul. “Even the best teams need the right structure to win,” Furner said back then. Reuters

Walmart plans to post its fourth-quarter results early Thursday, with numbers dropping at 6 a.m. CST. A live conference call—set for 7 a.m. CST—will be led by Furner and CFO John David Rainey, according to the company.

Volatility’s the backdrop, and it’s not letting up. “It’s all this whack-a-mole game” when it comes to guessing which corner of the market AI might shake up next, B Riley Wealth’s chief market strategist Art Hogan wrote, weighing in on the shifting stories sweeping through different sectors. Mark Hackett, chief market strategist over at Nationwide, pointed out that this rotation away from the previous cycle’s big names “is getting embedded into the psychology of investors.” Reuters

Walmart draws focus as traders hunt for new signals on consumer demand—groceries and essentials under the microscope. Margins? Any shift there will get attention. Investors are also listening closely for management’s commentary on pricing, labor and logistics costs, plus any updates on higher-margin segments like advertising and online services.

Still, there’s risk in both directions here. Walmart’s stock climbed into the report, so anything less than a solid outlook could sting, especially for a name that’s priced assuming no missteps. If shoppers are slowing down more than headline numbers indicate, the impact probably won’t stop with Walmart; the whole sector could feel it.

Markets come back online Tuesday after the holiday. Walmart drops results Thursday; investors will weigh the retailer’s outlook with fresh GDP and PCE inflation data in the mix—numbers that could sway rate-cut bets and, in turn, trading sentiment.

Stock Market Today

  • KOSPI Index Plunges Amid Global Market Turmoil
    June 8, 2026, 9:07 AM EDT. South Korea's KOSPI experienced a sharp crash triggered by margin stress in chip stocks and a circuit breaker trading halt. The selloff in global markets was fueled by a strong U.S. jobs report signaling prolonged high interest rates, fears of a yen carry trade unwind amid Bank of Japan tightening, and a crypto selloff following Zcash network vulnerabilities. U.S. futures rebounded slightly as chip stocks recovered, with investors focused on upcoming inflation data and SpaceX's anticipated IPO. Rising Middle East tensions keep oil prices elevated near $94 per barrel. The volatile market reflects growing concerns over liquidity absorption from the SpaceX listing, geopolitical risks, and tightening monetary policies globally.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
DraftKings stock price tumbles after 2026 outlook miss; what DKNG traders watch next
Previous Story

DraftKings stock price tumbles after 2026 outlook miss; what DKNG traders watch next

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop